Investing to become financially independent
Investing to become financially independent
Discover the similarities between dividend-oriented and capital-gain-oriented investing, as well as the essential pillars for success in the stock market. This in-depth analysis reveals the importance of diversification, setting clear goals and consistency in your long-term investment strategy.
Dividends: to be or not to be? (conclusion) Read More »
To thank my readers for their loyalty, I have added a new page of information on the stocks followed in the Global Dividend Growers strategy portfolio. By clicking on the name of the stock, for example Colgate-Palmolive, you are taken to the "Stock Details" page which gives you detailed and up-to-date information
Discover Praxair Inc (NYSE:PX), a leading North and South American supplier of industrial gases, distinguished by its global presence and impressive patent portfolio. Despite solid stock performance and stable dividend growth, its current valuation suggests a holding strategy for existing investors rather than a new buying opportunity.
Johnson & Johnson, an American healthcare giant founded in 1886, is one of the world's largest manufacturers of pharmaceutical, medical and cosmetic products with iconic brands such as Tylenol, Band-Aid and Neutrogena. The company stands out for its impressive history of growing dividends for decades, offering attractive stability for investors despite a slightly high payout ratio.
Johnson & Johnson (NYSE:JNJ) Read More »
An in-depth analysis of different investment strategies, comparing the price action approach advocated by the Very Particular Investor with the dividend-based approach. The article explores in particular the case of Apple (AAPL) and demonstrates how these two approaches can actually be complementary rather than opposed to optimize its stock market returns.
Dividends: to be or not to be? (episode 3) Read More »
Discover Sigma-Aldrich, the American giant in the production of chemicals and equipment for scientific research, present worldwide with over a million customers. Despite its defensive nature and reasonable volatility, the share currently offers a high valuation that merits careful monitoring before any investment.
Sigma-Aldrich (Nasdaq:SIAL) Read More »
The article presents a fascinating debate between two approaches to stock market investment: capital gains trading and dividend growth investing. Through a series of detailed analyses, the authors explore the advantages of each strategy, with a particular focus on the dividend growth method which allows for attractive returns over the long term.
Dividends: to be or not to be? (episode 1) Read More »
Abbott Laboratories, an American pharmaceutical company founded in Chicago, stands out for its solid development in healthcare with a promising pipeline of medical and pharmaceutical products. With a strong international presence, stable dividend growth and controlled volatility, Abbott positions itself as an attractive defensive investment for investors seeking long-term stability.